癌症治疗中的 TRAIL 功能化纳米粒子:分子机制和转化机会
Dasari Sahithi1, Urushi Rehman1, Ramasubbamma Ramaiah2
1Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
Critical reviews in oncology/hematology
|January 25, 2026
概括
与瘤亡因子相关的诱导亡联体 (TRAIL) 纳米颗粒通过改善药物输送和克服耐药性来增强癌症治疗. 这种纳米技术方法显示了个性化癌症治疗的前景.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- 与瘤亡因子相关的诱导亡的配体 (TRAIL) 选择性地诱导癌细胞死亡,但面临着快速清除和瘤耐药性等临床挑战.
- 纳米技术提供了解决方案来稳定 TRAIL,改善其药理动力学,并使瘤的向输送成为可能.
- 基于 TRAIL 的纳米药物有可能克服药物耐药性,并在癌症治疗中增强亡信号传递.
研究的目的:
- 审查TRAIL介导的亡机制和TRAIL功能化的纳米颗粒的设计.
- 探索TRAIL纳米药物与协同治疗策略的整合.
- 讨论TRAIL纳米药在精密瘤学中的转化潜力和未来方向.
主要方法:
- 在各种癌症模型 (例如,三阴性乳腺癌,质母细胞瘤,结直肠癌) 中对TRAIL功能化纳米颗粒进行临床前研究的综述.
- 基于脂质,聚合物和金属纳米粒子设计的分析,用于TRAIL交付.
- 检查涉及TRAIL纳米药物与化疗,敏感剂或免疫调节剂的组合策略.
主要成果:
- 功能化的纳米颗粒显示出增强的治疗效率和瘤特异性的积累.
- 这些纳米载体提高了TRAIL的生物可用性和稳定性,克服了药物动力学限制.
- 使用 TRAIL 纳米颗粒的组合方法显示出克服内在或获得的瘤耐药性的潜力.
- 临床前研究报告说,与传统的TRAIL药物相比,系统性毒性降低了.
结论:
- 功能化的纳米粒子代表了精密瘤学的有希望的战略,将分子疗法与纳米技术相结合.
- 这种方法具有显著的翻译潜力,可以通过提高 TRAIL 疗效和降低毒性来实现个性化癌症治疗.
- 需要进一步的研究和开发来推动TRAIL纳米药物进入临床应用.
更多相关视频
10:51Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy
Published on: August 28, 2013
11.2K
08:07Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
Published on: November 23, 2019
11.8K
相关概念视频
Mechanical Protein Functions
5.5K
Proteins perform many mechanical functions in a cell. These proteins can be classified into two general categories- proteins that generate mechanical forces and proteins that are subjected to mechanical forces. Proteins providing mechanical support to the structure of the cell, such as keratin, are subjected to mechanical force, whereas proteins involved in cell movement and transport of molecules across cell membranes, such as an ion pump, are examples of generating mechanical force.
5.5K
Cancer Therapies
9.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Targeted Cancer Therapies
8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.7K
Mechanical Protein Function
2.5K
2.5K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Translation
156.0K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.0K
